Colorectal Neoplasia Screening w Colonoscopy in Asymptomatic Women at Regional Navy/Army Medical Ctrs: The CONCeRN Trial
Diet, Other Risk Factors, Genetics and the Risk of Colorectal Neoplasia in a Screening Trial of Asymptomatic Women: A Sub-Study of the CONCeRN Trial
2 other identifiers
observational
937
1 country
3
Brief Summary
The CONCeRN Trial is a multi-center study of asymptomatic women between the ages of 40 and 75 referred to regional military medical centers for routine colorectal screening. The primary purpose of the main study is to determine the extent to which advanced neoplastic lesions will be missed if clinicians only perform sigmoidoscopies rather than full colonoscopies as a screening procedure and to resolve current debate about the significance of sigmoidoscopic detection of single, small, tubular adenomas (i.e., do they imply greater risk for large adenomatous polyps or colorectal cancer at other sites beyond the reach of the sigmoidoscope, or is there no increased risk?). Women enrolled in the trial receive colonoscopy during which all identified polyps are removed and also during which two pinch biopsies of apparently-normal tissue are taken. In addition, before the colonoscopy is performed, patients wil have blood drawn and answer a brief questionnaire on risk factors for colorectal cancer. The sub-study proposes to add on a more extensive questionnaire to assess dietary and other lifesyle factors potentially related to colorectal cancer, and to draw additional blood for assessment of nutritional status and for analysis of genetic polymorphisms related to colorectal cancer. With the additional information available from these questionnaires and blood samples, it will be possible to explore the extent to which various dietary and genetic risk factors are related to colorectal polyps in asymptomatic women of average risk for disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2000
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 14, 2000
CompletedFirst Submitted
Initial submission to the registry
June 19, 2006
CompletedFirst Posted
Study publicly available on registry
June 21, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 16, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 16, 2020
CompletedJuly 17, 2020
July 1, 2020
20.4 years
June 19, 2006
July 16, 2020
Conditions
Keywords
Study Arms (1)
1
Asymptomatic women between the ages of 40 and 75 referred to regional military medical centers for routine colorectal screening
Eligibility Criteria
Asymptomatic women between the ages of 40 and 75 referred to regional military medical centers for routine colorectal screening@@@
You may qualify if:
- , asymptomatic women of average risk referred for colorectal screening.
- year-old asymptomatic women referred for colorectal screening with a history of colorectal cancer in a first degree relative.
You may not qualify if:
- History of positive stool guiaic within six months of referral.
- History of iron deficiency anemia within six months of referral (Note: if patients have not had stool guiacs, complete blood cell count or ferritin performed within the last six months, then these tests will be performed at time of study enrollment).
- History of normal colonoscopy or barium enema within past ten years or history of normal flexible sigmoidoscopy within past 5 years.
- History of adenomatous polyps, colorectal cancer, inflammatory bowel disease, HNPCC, or familial adenomatous polyposis.
- History of rectal bleeding or hematochezia within the past 12 months.
- Unintentional weight loss greater than 10 pounds within previous six months.
- Pregnant women.
- Subjects under 18 years of age.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Naval Medical Center, San Diego
San Diego, California, 92134-5000, United States
National Naval Medical Center
Bethesda, Maryland, 20889, United States
Naval Medical Center, Portsmouth
Portsmouth, Virginia, 23708, United States
Related Publications (3)
Adamson RH, Thorgeirsson UP, Snyderwine EG, Thorgeirsson SS, Reeves J, Dalgard DW, Takayama S, Sugimura T. Carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates: induction of tumors in three macaques. Jpn J Cancer Res. 1990 Jan;81(1):10-4. doi: 10.1111/j.1349-7006.1990.tb02500.x.
PMID: 1691162BACKGROUNDBosron WF, Li TK. Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism. Hepatology. 1986 May-Jun;6(3):502-10. doi: 10.1002/hep.1840060330.
PMID: 3519419BACKGROUNDBoutron MC, Faivre J, Marteau P, Couillault C, Senesse P, Quipourt V. Calcium, phosphorus, vitamin D, dairy products and colorectal carcinogenesis: a French case--control study. Br J Cancer. 1996 Jul;74(1):145-51. doi: 10.1038/bjc.1996.330.
PMID: 8679449BACKGROUND
Biospecimen
blood, colon tissue
Study Officials
- PRINCIPAL INVESTIGATOR
Rashmi Sinha, Ph.D.
National Cancer Institute (NCI)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 19, 2006
First Posted
June 21, 2006
Study Start
February 14, 2000
Primary Completion
July 16, 2020
Study Completion
July 16, 2020
Last Updated
July 17, 2020
Record last verified: 2020-07